Decitabine Treatment of Glioma-Initiating Cells Enhances Immune Recognition and Killing

Malignant gliomas are aggressive brain tumours with very poor prognosis. The majority of glioma cells are differentiated (glioma-differentiated cells: GDCs), whereas the smaller population (glioma-initiating cells, GICs) is undifferentiated and resistant to conventional therapies. Therefore, to bett...

Descripción completa

Detalles Bibliográficos
Autores principales: Riccadonna, Cristina, Yacoub Maroun, Céline, Vuillefroy de Silly, Romain, Boehler, Margaux, Calvo Tardón, Marta, Jueliger, Simone, Taverna, Pietro, Barba, Leticia, Marinari, Eliana, Pellegatta, Serena, Bassoy, Esen Yonca, Martinvalet, Denis, Dietrich, Pierre-Yves, Walker, Paul R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5007044/
https://www.ncbi.nlm.nih.gov/pubmed/27579489
http://dx.doi.org/10.1371/journal.pone.0162105

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5007044/
https://www.ncbi.nlm.nih.gov/pubmed/27579489
http://dx.doi.org/10.1371/journal.pone.0162105

Ejemplares similares